Athira Nair

https://www.coherentmarketinsights.com/insight/request-sample/2414

https://www.coherentmarketinsights.com/insight/request-pdf/2414

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2414

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/influenza-diagnostics-market-2414

Epidural Anesthesia Disposable Devices Market Analysis (2020-2027)

2021-01-14T12:03:45.225Z

Epidural anesthesia, also called as regional anesthesia blocks pain in a particular area of the body by blocking nerve impulses into the epidural space around the spinal cord. This aids in reducing sensation of lower part of the body. Epidural anesthesia is the most common method to reduce pain during normal or C-section delivery. Epidural anesthesia is a disposable device used in epidural analgesia or combined spinal-epidural anesthesia to produce regional anesthesia in the sub-arachnoid space with the help of fine needle.

Market Dynamics

Increasing incidence of orthopedic surgeries, vascular surgeries, and others are expected to propel growth of epidural anesthesia disposable devices market during the forecast period. Orthopedic surgeries include surgical procedures for pelvic fractures and hip and knee surgeries, and vascular surgeries include revascularization procedures and amputation of lower extremity. For instance, according to the National Vascular Registry, 2018 around 9,293 major lower limb amputation were performed from 2015 to 2017, of which around 4,398 and 4,895 surgeries were above knee and below knee amputations, respectively, across the U.K.

Increasing demand for epidural anesthesia disposable devices for patients undergoing lumbar decompression surgery and increasing usage of epidural anesthesia during labor are expected to boost growth of the global epidural anesthesia disposable devices market over the forecast period. For instance, according to the World Health Organization reports published in 2018, the percentage of deliveries with labor analgesia in countries such as Singapore and South Korea were around 60% and 40%, respectively during 2016-2017.

Furthermore, rising adoption of inorganic growth strategies such as acquisitions and collaborations by the market players are expected to drive growth of the global epidural anesthesia disposable devices market over the forecast period. For instance, in January 2019, Omeq Medical Ltd. entered into a collaboration with Pharos Medical, a China-based manufacturer and distributor of medical devices, in order to gain entry in the China epidural market for its smart epidural devices. Under the collaboration, Omeq's smart epidural needle will be commercialized in China by Pharos Medical.

Key features of the study:

· This report provides in-depth analysis of the epidural anesthesia disposable devices market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year

· It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

· This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

· It profiles key players in the global epidural anesthesia disposable devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

· Key companies covered as part of this study include B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, Smiths Medical, Sarstedt, Inc., Epimed, Egemen International, SFM Medical Devices, VOGT Medical, Vygon, and Flat Medical

· Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics

· The global epidural anesthesia disposable devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

· Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the epidural anesthesia disposable devices market

Detailed Segmentation:

· Global Epidural Anesthesia Disposable Devices Market, By Product Type:

o Continuous Epidural Tray

o Single Dose Epidural Tray

o Epidural Anesthesia Needles

o Others

· Global Epidural Anesthesia Disposable Devices Market, By Age Group:

o Adults

o Pediatrics

· Global Epidural Anesthesia Disposable Devices Market, By End User:

o Hospitals

o Surgical Centers

o Others

· Global Epidural Anesthesia Disposable Devices Market, By Region:

o North America

§ By Product Type:

§ Continuous Epidural Tray

§ Single Dose Epidural Tray

§ Epidural Anesthesia Needles

§ Others

§ By Age Group:

§ Adults

§ Pediatrics

§ By End User:

§ Hospitals

§ Surgical Centers

§ Others

§ By Country:

§ U.S.

§ Canada

o Latin America

§ By Product Type:

§ Continuous Epidural Tray

§ Single Dose Epidural Tray

§ Epidural Anesthesia Needles

§ Others

§ By Age Group:

§ Adults

§ Pediatrics

§ By End User:

§ Hospitals

§ Surgical Centers

§ Others

§ By Country:

§ Brazil

§ Mexico

§ Argentina

§ Rest of Latin America

o Europe

§ By Product Type:

§ Continuous Epidural Tray

§ Single Dose Epidural Tray

§ Epidural Anesthesia Needles

§ Others

§ By Age Group:

§ Adults

§ Pediatrics

§ By End User:

§ Hospitals

§ Surgical Centers

§ Others

§ By Country:

§ Germany

§ U.K.

§ France

§ Italy

§ Spain

§ Russia

§ Rest of Europe

o Asia Pacific

§ By Product Type:

§ Continuous Epidural Tray

§ Single Dose Epidural Tray

§ Epidural Anesthesia Needles

§ Others

§ By Age Group:

§ Adults

§ Pediatrics

§ By End User:

§ Hospitals

§ Surgical Centers

§ Others

§ By Country:

§ China

§ India

§ Japan

§ Australia

§ South Korea

§ ASEAN

§ Rest of Asia Pacific

o Middle East

§ By Product Type:

§ Continuous Epidural Tray

§ Single Dose Epidural Tray

§ Epidural Anesthesia Needles

§ Others

§ By Age Group:

§ Adults

§ Pediatrics

§ By End User:

§ Hospitals

§ Surgical Centers

§ Others

§ By Country:

§ GCC

§ Israel

§ Rest of Middle East

o Africa

§ By Product Type:

§ Continuous Epidural Tray

§ Single Dose Epidural Tray

§ Epidural Anesthesia Needles

§ Others

§ By Age Group:

§ Adults

§ Pediatrics

§ By End User:

§ Hospitals

§ Surgical Centers

§ Others

§ By Country/Region:

§ South Africa

§ Central Africa

§ North Africa

· Company Profiles

o Braun Melsungen AG*

§ Company Overview

§ Product Portfolio

§ Financial Performance

§ Key Highlights

§ Market Strategies

o Becton, Dickinson and Company

o Teleflex Incorporated

o Smiths Medical

o Sarstedt, Inc.

o Epimed

o Egemen International

o SFM Medical Devices

o VOGT Medical

o Vygon

o Flat Medical

https://www.coherentmarketinsights.com/insight/request-sample/2413

https://www.coherentmarketinsights.com/insight/request-pdf/2413

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2413

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/market-insight/epidural-anesthesia-disposable-devices-market-2413

Microneedling Devices Market Analysis (2020-2027)

2021-01-14T12:00:36.107Z

Microneedling is a safe, cosmetic, and derma roller procedure used for various skin treatments. This process is also called as collagen induction therapy. Microneedles are rolling devices that have several tiny needles, which penetrate in living layer of skin and trigger collagen and elastin production. Microneedling is used for various skin-related complications such as fine lines, acne, scarring, wrinkles, loose skin, stretch marks, and pigmentation.

Global Microneedling Devices Market – Dynamics

Increasing incidences of uneven skin tone and skin discoloration are expected to boost growth of the microneedling devices market. According to a report by The Journal of Clinical and Aesthetic Dermatology, in July 2010 published, the prevalence of uneven skin tone and skin discoloration in Arab Americans was around 56.4% and 55.9%, in 2007 respectively. Moreover, increasing cost of cosmetic surgeries and high discomfort level of such surgeries as compared to microneedling procedure is also expected to boost growth of the global market for microneedling devices. According to the National Center for Biotechnology Information (NCBI) report in August 2017, the microneedling procedure is well tolerated with less discomfort and pain. Moreover, the procedure has less side effects compared to other invasive treatment such as radio frequency and laser treatment. According to the National Institute of Health (NIH) in June 2017, the innovation in the microneedle patch for vaccination of flu is expected to boost the microneedling market over the forecast period.

Global Microneedling Devices Market – Regional Insights

North America accounted for the largest market share in 2017, owing to launch and approval of new microneedling devices in the region. For instance, the U.S. Food and Drug Administration (FDA) approved a microneedling device (SkinPen®) developed by Bellus Medicals, a U.S.-based company. Increasing prevalence of skin-related diseases is expected to boost growth of the microneedling devices market in Asia Pacific. According to the Indian Journal of Dermatology, In India over 80% of the population has skin color heterogeneity results from postinflammatory hyperpigmentation or melasma. Therefore, these factors and scenarios are expected to boost growth of the global microneedling devices market.

Global Microneedling Devices Market – Competitive Landscape

Key players operating in the global microneedling devices market include, Dermapen, Dermaroller GmbH, MDPen Fractional Microdermal Needling, DermaConcepts, ConceptSkincare, Ramboll Environ, Inc., Edge Systems LLC., Weyergans High Care, Bomtech Electronics Co., Ltd., and others.

Key players in the market are focused on developing new products in order to enhance their market share. For instance, Dermaroller GmbH developed – Dermaroller HC902 and Beauty Mouse that can be used at home by patients. In 2013, the company was awarded by the professional magazine ‘Ästhetische Dermatologie.’ for the product Dermaroller Beauty Mouse.

Global Microneedling Devices Market - Taxonomy

On the basis of product type, the global microneedling devices market is segmented into:

· Derma-stamp

· Dermapen

· Dermarollers

On the basis of needle material, the global microneedling devices market is segmented into:

· Silicon Microneedle

o Silicon Hollow Microneedle

o Solid Microneedle

· Metal Microneedle

o Hollow Metal Microneedle

o Solid Metal Microneedle

· Glass Microneedle

On the basis of end user, the global microneedling devices market is segmented into:

· Hospitals

· Dermatology Clinics

· Others

On the basis of regions, the global microneedling devices market is segmented into:

· North America

· Latin America

· Europe

· Asia Pacific

· Middle East

· Africa

https://www.coherentmarketinsights.com/insight/request-sample/2415

https://www.coherentmarketinsights.com/insight/request-pdf/2415

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2415

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/microneedling-devices-market-2415

Dental CAD/CAM Devices Market Analysis (2020-2027)

2021-01-14T11:59:00.822Z

Dental computer-aided design and computer-aided manufacturing (CAD/CAM) systems work very precisely to help dentists to create highly effective designs and restorations. It consists of 3D dental design software, digital impression system, and a milling device, which completes the whole digital workflow procedure of dental restoration. It has increased patient satisfaction and feasibility, as the procedures are carried out in single appointment. The final results can be regulated and handled by dentists easily, which has boosted the market growth.

Global Dental CAD/CAM Devices Market – Dynamics

Growing demand for tooth-colored onlays and inlays, tooth whitening veeners, and tooth-colored crowns are expected to increase demand for cosmetic dentistry, thereby positively impacting the global dental CAD-CAM market growth. Rising geriatric population and increasing demand for dental cosmetic surgeries have accelerated the number of dental CAD-CAM device-aided surgeries. According to the American Academy of Cosmetic Dentistry (AACD), major dental patients fall in the age category of 40 years, which is 26.88% and age category of 50 years, which is 25.09%, this increases the demand for dental CAD/CAM devices and therefore, drives growth of the market.

Global Dental CAD/CAM Devices Market – Regional Insights

The U.S. accounted for the largest market share in the global dental CAD/CAM devices market, owing to rapid adoption of digital restorations. North America holds significant market share in the market due to high prevalence of dental caries. According to the Centers for Disease Control and Prevention (CDC) report of 2017, 31.6% patients with dental caries were untreated in the U.S from 2011-2014. Asia Pacific is expected to witness significant growth rate over the forecast period, owing to increasing geriatric population. Increasing awareness about health problems and significant adoption of automation and advancements in technology are expected to drive growth of the global dental CAD/CAM market over the forecast period.

Global Dental CAD/CAM Devices Market: Competitive Landscape

Key players operating in the global dental CAD/CAM devices market include Align Technology Inc., Axsys Incorporated, DATRON AG, Dentsply Sirona, KaVo Dental GmbH, B&D Dental Technologies, PLANMECA OY, Roland DGA Corporation, Straumann, Yenadent Ltd, and 3Shape A/S. Other key players include Amann Girrbach, Enhanced Geometry Solutions (EGS), Jensen Dental, Ivoclar Vivadent, and Schütz Dental. In 2018, the new software package for dental system was designed by 3Shape A/S.

Global Dental CAD/CAM Devices Market: Taxonomy

On the basis of product type, the global dental CAD/CAM devices market is segmented into

· Milling Machines

· Scanners

· Software

On the basis of application, the global dental CAD/CAM devices market is segmented into

· Crowns

· Dentures

· Bridges

· Veneers

· Inlays/Onlays

· Others

On the basis of end user, the global dental CAD/CAM devices market is segmented into

· Dental Laboratories

· Dental Clinics

· Research Institutes

On the basis of regions, the global dental CAD/CAM devices market is segmented into

· North America

· Latin America

· Europe

· Asia Pacific

· Middle East

· Africa

https://www.coherentmarketinsights.com/insight/request-sample/2412

https://www.coherentmarketinsights.com/insight/request-pdf/2412

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2412

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/dental-cad-cam-devices-market-2412

Rivastigmine Market Analysis (2020-2027)

2021-01-14T08:14:02.193Z

Rivastigmine is a cholinesterase enzyme inhibitor, which acts on butylcholinesterase and acetylcholinesterase. It is a cholinergic agent that aids in the treatment of Alzheimer’s and Parkinson’s disease. The drug can be administered orally or in transdermal patches form, owing to its small molecular size.

Rivastigmine Market – Dynamics

Increasing geriatric population is a major driver for growth of the rivastigmine market. According to The Alzheimer Association, in 2018, the risk of suffering from dementia can increase double fold above the age of 65 years in every 5 years. Moreover, increasing prevalence of cardiovascular diseases worldwide also accounts for the development of Alzheimer’s disease, thereby boosting demand for rivastigmine. As per the National Center for Biotechnology Information published in 2013, the incidence of cardiovascular diseases was around 22.5 per 1,000 person worldwide which in turn suggesting a risk of dementia.Diseases such as diabetes and blood pressure can also increase the risk of dementia, which further boosts demand for rivastigmine, thereby propelling the market growth.

Rivastigmine Market – Regional Insights

The rivastigmine market is segregated geographically into North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America accounted for the largest share in the global rivastigmine market in 2017. This is owing to increasing prevalence of chronic kidney disease in the region that may lead to dementia. According to The American Kidney Fund, around 31 million people suffered from chronic kidney disease in 2015. Europe accounted for the second largest share in terms of revenue in the global rivastigmine market, in 2017 owing to increasing geriatric population in the region. Geriatric population is more prone to dementia. According to World Population Prospects (WPP), in 2017, around 25% of the population in Europe was aged 60 years or above. According to the Alzheimer’s Association, in 2017, there was significant prevalence of vascular diseases in Latin America and Africa. Therefore, Latin America and Africa are expected to witness significant growth in the global rivastigmine market during the forecast period.

Rivastigmine Market – Competitive Landscape

Major players operating in the global rivastigmine market include, Novartis Europharm Limited, Actavis Pharma, Apotex Corporation, Aurobindo Pharm Ltd, Teva Pharmaceuticals Industries Ltd, Dr. Reddy’s Laboratories, Macleods, and others. Key players in the market are focused on product development and approvals in order to enhance their market share. For instance, in 2007, U.S. FDA approved Exelon (Rivastigmine tartarate) — developed by Novartis Europharm Limited for the treatment of Alzheimer's and Parkinson's disease.

Global Rivastigmine Market Taxonomy:

On the basis of disease indication, the global rivastigmine market is segmented into:

· Alzheimer’s disease

· Parkinson’s disease

On the basis of formulation, the global rivastigmine market is segmented into:

· Capsules

· Transdermal Patches

On the basis of distribution channel, the global rivastigmine market is segmented into:

· Hospital pharmacies

· Retail pharmacies

· Online pharmacies

On the basis of geography, the global rivastigmine market is segmented into:

· North America

· Latin America

· Europe

· Asia Pacific

· Middle East

· Africa

https://www.coherentmarketinsights.com/insight/request-sample/2407

https://www.coherentmarketinsights.com/insight/request-pdf/2407

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2407

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/rivastigmine-market-2407

Blood Screening Market Analysis (2020-2027)

2021-01-14T08:12:38.551Z

A blood screening is the process of laboratory testing for extracting blood prior to blood transfusion. The test is performed to ensure that recipients receive safe blood products. There are various blood screening procedures for donated blood to ensure that blood units are safe. Blood samples collected during donation undergo laboratory screening for Transfusion-Transmissible Infections (TTIs). In screening technique, blood sample is tested for evidence of certain infectious disease pathogens such as hepatitis B and C viruses and human immunodeficiency virus (HIV). There are different types of assay used for blood screening, which include Immunoassays (IAs) and nucleic acid amplification technology (NAT) assays. Immunoassays (IAs) is further subcategorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays, and rapid/simple single-use assays (rapid tests).

Blood Screening Market- Drivers

Increasing demand for NAT over ELISA (enzyme-linked immunosorbent assay) test due to high sensitivity and specificity for viral nucleic acid is boosting growth of the blood screening market. For instance, in 2018, Grifols received approval from the U.S. Food & Drug Administration (FDA) for two blood screening assays- Procleix Ultrio Elite and Procleix WNV. Both assays run on the fully automated NAT blood screening platform: Procleix Panther system. The Procleix Panther system with these assays helps blood centers to efficiently screen for infectious diseases and eliminates the need of batch processing.

Increasing number of blood donations campaigns by the government, blood donor agencies, and NGO’s are expected to propel growth of the blood screening market. For instance, according to the WHO reported data in June 2017, around 112.5 million blood donations are collected globally and around half of these are collected in high-income countries, highlighting 19% of the world’s population. Moreover, increase in initiatives by the government to create awareness among the people regarding safety of the donated blood is expected to drive growth of the market. For instance, in 2014, World Health Organization (WHO) recommended to establish a national blood system with well-organized and coordinated blood transfusion services, effective evidence-based and ethical national blood policies, and legislation and regulation that can provide sufficient and timely supplies of safe blood and blood products to meet the transfusion needs of all patients.

However, shortages of trained staff and poor quality systems, which results in inefficient screening systems, inadequate procedures for identification, and misidentification of patient or donor blood samples are some of the factors restraining growth of the market.

Blood Screening Market- Regional Analysis

On the basis of region, the global blood screening market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to dominate the blood screening market, owing to acquisitions by major players in the region. For Instance, in July 2017, Grifols acquired the NAT (Nucleic Acid Testing) donor screening unit from the U.S. Company Hologic for a purchase price of US$ 1,850 Million. This agreement bound to research, development, and manufacture of assays and instruments activities by using NAT technology that allows detection of infectious agents present in blood and plasma donations, contributing to greater transfusion safety.

Asia Pacific is expected to witness significant growth in the blood screening market due to increasing government initiatives and rising awareness regarding transmission of diseases during blood transfusion. For instance, in June 2015, a National Blood Donor Vigilance Programme (NBDVP) was launched in India on the World Blood Donor Day. The objectives of the NBDVP is to increase blood donation frequency and reduce the frequency of adverse event and to analyze the risk factor and evaluate preventive measure.

Blood Screening Market- Competitive Landscape

Key Player operating in the blood screening market include Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary of Danaher Corporation) and Becton, Dickinson and Company.

Key Development

· In July 2019, Abbott Laboratories, received the U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity s System. Alinity s System is designed to screen blood and plasma more efficiently in less space and also generate the test results consuming less tume and minimum human error.

· In 2018, LifeCell International Pvt. Ltd launched RightStart, an integrated DNA-based screening for the diagnosis of more than 50 medical conditions among newborn patients.

· In 2017, Clinical Genomics Pty Ltd, launched circulating tumor DNA (ctDNA) blood-based test for the detection of colorectal cancer.

· In 2016, Hologic, Inc and Grifols, S.A being in a partnership agreement, received the US Food and Drug Administration (FDA) approval for its Procleix Zika virus blood screening assay.

· In 2016, F. Hoffmann-La Roche Ltd, received US Food and Drug Administration (FDA) approval for its cobas MPX test applicable with analyzers like cobas 6800 and 8800 Systems for the detection of HIV-1, HIV-2, HBV and HCV.

Blood Screening Market- Taxonomy

By Technology:

· Nucleic acid amplification technology (NAT)

· ELISA

· Immunoassays (IAs)

· Next-Generation Sequencing (NGS)

· Western Blotting

By Product Type

· Reagents & Kits

· Instruments

By End User:

· Hospital

· Blood Banks

· Diagnostics Laboratory

By Region

· North America

· Europe

· Asia Pacific

· Latin America

· Middle East

· Africa

https://www.coherentmarketinsights.com/insight/request-sample/2409

https://www.coherentmarketinsights.com/insight/request-pdf/2409

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2409

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/blood-screening-market-2409

Clear Aligners Market Analysis (2018 – 2026)

2021-01-14T07:57:54.768Z

Clear aligners offer effective solutions to patients seeking discreet orthodontic treatment in comparison to conventional braces. This report provides a comprehensive view on the market trends, potential, opportunity, and competition, across different geographies.

Market Dynamics

Factors such as increasing patient awareness towards dental health, rising disposable income of the general population, increasing dental insurance for orthodontic procedures are factors expected to augment the market growth. The clear aligners market is expected to gain significant traction owing to increasing number of new entrants offering affordable products to patients. For instance, in May 2018, Henry Schein, Inc. launched orthodontic aligner with its proprietary SLX Clear Aligner System. The system incorporates Sagittal First/Motion 3D technology that offers patients and clinicians a simplified treatment process by reducing the number of aligners used. However, high product cost of clear aligners restricts adoption of the products in low income economies, hindering the market growth.

Key features of the study:

· This report provides in-depth analysis of the clear aligners market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2018, as the base year

· It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

· This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

· It profiles key players in the global clear aligners market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

· Key companies covered as a part of this study include, Align Technology, Inc., DynaFlex, Dentsply Sirona, Inc., SmileDirectClub, Straumann Group, Danaher Corporation, Henry Schein, Inc., Great Lakes Dental Technologies, Rocky Mountain Orthodontics, and eXceed.

· Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

· The global clear aligners market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

· Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the clear aligners market

Detailed Segmentation:

· Global Clear Aligners Market, By Material Type:

o Polyurethane Plastic

o Polyethylene Terephthalate Glycol (PETG)

o Poly-vinyl Chloride (PVC)

o Others

· Global Clear Aligners Market, By Age Group:

o Children

o Adults

· Global Clear Aligners Market, By End User:

o Hospitals

o Dental Clinics

· Global Clear Aligners Market, By Geography:

o North America

§ By Material Type:

§ Polyurethane Plastic

§ Polyethylene Terephthalate Glycol (PETG)

§ Poly-vinyl Chloride (PVC)

§ Others

§ By Age Group:

§ Children

§ Adults

§ By End User:

§ Hospitals

§ Dental Clinics

§ By Country:

§ U.S.

§ Canada

o Latin America

§ By Material Type:

§ Polyurethane Plastic

§ Polyethylene Terephthalate Glycol (PETG)

§ Poly-vinyl Chloride (PVC)

§ Others

§ By Age Group:

§ Children

§ Adults

§ By End User:

§ Hospitals

§ Dental Clinics

§ By Country:

§ Brazil

§ Mexico

§ Argentina

§ Rest of Latin America

o Europe

§ By Material Type:

§ Polyurethane Plastic

§ Polyethylene Terephthalate Glycol (PETG)

§ Poly-vinyl Chloride (PVC)

§ Others

§ By Age Group:

§ Children

§ Adults

§ By End User:

§ Hospitals

§ Dental Clinics

§ By Country:

§ Germany

§ U.K.

§ France

§ Italy

§ Spain

§ Russia

§ Rest of Europe

o Asia Pacific

§ By Material Type:

§ Polyurethane Plastic

§ Polyethylene Terephthalate Glycol (PETG)

§ Poly-vinyl Chloride (PVC)

§ Others

§ By Age Group:

§ Children

§ Adults

§ By End User:

§ Hospitals

§ Dental Clinics

§ By Country:

§ China

§ India

§ Japan

§ Australia

§ South Korea

§ ASEAN

§ Rest of Asia Pacific

o Middle East

§ By Material Type:

§ Polyurethane Plastic

§ Polyethylene Terephthalate Glycol (PETG)

§ Poly-vinyl Chloride (PVC)

§ Others

§ By Age Group:

§ Children

§ Adults

§ By End User:

§ Hospitals

§ Dental Clinics

§ By Country:

§ GCC

§ Israel

§ Rest of Middle East

o Africa

§ By Material Type:

§ Polyurethane Plastic

§ Polyethylene Terephthalate Glycol (PETG)

§ Poly-vinyl Chloride (PVC)

§ Others

§ By Age Group:

§ Children

§ Adults

§ By End User:

§ Hospitals

§ Dental Clinics

§ By Country:

§ South Africa

§ Central Africa

§ North Africa

· Company Profiles

o Align Technology, Inc.*

§ Company Overview

§ Material Portfolio

§ Financial Performance

§ Key Highlights

§ Market Strategies

o DynaFlex

o Dentsply Sirona, Inc.

o SmileDirectClub

o Straumann Group

o Danaher Corporation

o Henry Schein, Inc.

o Great Lakes Dental Technologies

o Rocky Mountain Orthodontics

o eXceed

https://www.coherentmarketinsights.com/insight/request-sample/2411

https://www.coherentmarketinsights.com/insight/request-pdf/2411

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2411

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/market-insight/clear-aligners-market-2411

Cranial Stabilization Devices Market Analysis (2020-2027)

2021-01-14T07:56:17.405Z

Cranial stabilization is a process of making the cranial nerves stable for brain surgery. Brain surgery is also known as craniotomy. A craniotomy is dependent on the nature of brain problem. It is majorly performed to aid in treatment of brain tumors, hematomas (blood clots), aneurysms or arteriovenous malformation (AVM), traumatic head injury, foreign objects (bullets), swelling of the brain, or infection.

Cranial Stabilization Devices Market – Drivers

Increasing prevalence of neurological disorders is expected to boost the cranial stabilization devices market growth during the forecast period. For instance, in 2015, Global Burden of Disease Study surveyed that neurological disorders are the major cause of disability and death worldwide. The burden of neurological disorders has increased by 36·7% over the past 25 years from 1990 to 2015.

Cranial Stabilization Devices Market – Restraints

Several medical device reimbursement challenges is expected to hamper the cranial stabilization devices market growth. In many countries, the medical device reimbursement rates are based on standing formulas applied to the procedure or types of device and not on the technology or features of the individual manufacturer. This prevents medical device manufacturing companies to invest in the development of medical devices with advanced technologies.

Cranial Stabilization Devices Market – Regional Analysis

On the basis of region, the global cranial stabilization devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing merger and acquisition activities in North America are expected to drive the cranial stabilization devices market size in the region. For instance, in October 2017, Integra LifeSciences Holdings Corporation acquired the Johnson & Johnson’s Codman Neurosurgery business. The Codman Neurosurgery business offers a portfolio of devices focused on hydrocephalus management, neuro intensive care, and cranial surgery. The deal was closed for US$ 1.045 billion.

Furthermore, Asia Pacific is expected to witness significant cranial stabilization devices market growth, owing to increasing initiatives by various organizations to promote the development of clinical neurology and neurological science in Asia Pacific. For Instance, in November 2018, the Asian and Oceanian Association of Neurology (AOAN) hosted the conference: The Asian Oceanian Congress of Neurology 2018 (AOCN 2018), to provide participants (neurologists) an unparalleled insights into the latest research, developments, and treatments in the field of neurosciences through its comprehensive scientific program led by regional neurology experts.

Key Players in the Cranial Stabilization Devices Market:

Key players operating in the cranial stabilization devices market include, Integra Lifesciences Holdings Corporation, Jintan Huida Medical Instrument Co. Ltd., B. Braun Melsungen AG, DePuy Synthes, evonos GmbH & Co. KG, Jeil Medical Corporation, Medtronic, Micromar, NEOS Surgery, OsteoMed, Pro Med Instruments, Stryker, and Zimmer Biomet.

Cranial Stabilization Devices Market – Taxonomy

By Product type

· Skull Clamp

· Brain Retractor System

· Horseshoe Headrests

· Accessories

By End User

· Hospitals

· Ambulatory Surgical Centers

· Specialty Centers

By Region

· North America

· Europe

· Asia Pacific

· Latin America

· Middle East

· Africa

https://www.coherentmarketinsights.com/insight/request-sample/2410

https://www.coherentmarketinsights.com/insight/request-pdf/2410

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2410

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/cranial-stabilization-devices-market-2410

Heart Transport Systems Market Analysis (2020-2027)

2021-01-13T17:45:58.679Z

Heart transport systems are devices used for maintenance and nourishment of heart while it is being transported from harvest in preparation for transplantation. Heart transportation is a highly critical process as the heart can only be preserved for around 4 hours in an ice box. Advanced transport systems such as LifeCradle product developed by Organ Transport Systems can preserve heart for 12 hours.

The Global Heart Transport System – Market Dynamics

Increasing prevalence of cardiovascular diseases that often require heart transplant surgeries and government initiatives in funding for research and development in heart transplant surgeries are major factors driving growth of the global heart transport systems market. According to The International Society for Heart and Lung Transplantation, in 2014, around 586 heart transplant surgeries were performed worldwide. Increasing stress among the populace along with sedentary work, high fat intake, and congenital defects in heart also increase demand for heart transplant. This in turn boosts growth of the global heart transport systems market.

The Global Heart Transport Systems Market – Regional Insights

North America accounted for the largest share in the global heart transport systems market in 2017, owing to increasing number of people diagnosed with coronary artery disease, heart failure, and cardiomyopathy. According to the U.S. Pediatric Cardiomyopathy Registry, the annual incidence of cardiomyopathy in the U.S. was around 1.13 per 10, 00,000 children younger than 18 years of age. Europe accounted for the second largest share in the market in terms of revenue, owing to increasing research and development activities in heart transport systems. . Market in Asia Pacific is expected to witness the fastest growth, owing to increasing geriatric population in the region increases prevalence of cardiovascular disease. For instance, according to a report published by Asia Pacific Journal, in 2018, 7 out of 10 deaths are expected to cause due to cardiovascular diseases by 2020.

The Global Heart Transport System – Competitive Landscape

Major players operating in the global heart transport systems market include, Paragonix Technologies, Inc., Organ Transport Systems, Pulse Heart Transportation System, and others. Key players in the market are focused on launching new heart transport systems in order to enhance their market share. For instance, in December 2018, Paragonix Technologies received approval from the U.S. Food and Drug Administration (FDA) for its Paragonix Sherp, a cardiac transport system.

Global Heart Transport System Market Taxonomy

On the basis of disease indication, the global heart transport systems market is segmented into:

· Heart Failure

· Cardiomyopathy

· Congenital Heart Defect

· Coronary Heart Disease

· Others

On the basis of end user, the global heart transport systems market is segmented into:

· Hospitals

· Cardiac centers

· Research centers

On the basis of geography, the global heart transport systems market is segmented into:

· North America

· Latin America

· Europe

· Asia Pacific

· Middle East

· Africa

https://www.coherentmarketinsights.com/insight/request-sample/2405

https://www.coherentmarketinsights.com/insight/request-pdf/2405

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2405

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Reference/Source: https://www.coherentmarketinsights.com/ongoing-insight/heart-transport-systems-market-2405

Monoclonal Antibody Therapeutics Market Analysis (2020-2027)

2021-01-13T17:44:12.431Z

Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017, the U.S. Food & Drug Administration (FDA) approved Darzalex (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients suffering from multiple myeloma, who have received two prior therapies. These factors are expected to support growth of the market over the forecast period.

Market Dynamics

Rising incidence of cancer and other chronic diseases is a major factor that is expected to boost the monoclonal antibodies market growth over the forecast period. According to GLOBOCAN, in 2018, an estimated 43.6% new cases of breast cancer were registered in Asia Pacific. Also, according to the American Cancer Society, 2017, cancer was the second most common cause of death in the U.S., which accounted for around 1 out of every 4 deaths.

Market players are focused on combining monoclonal antibodies with other therapies such as chemotherapy drugs, which is expected to assist the market growth over the forecast period. For instance, combination of nivolumab and ipilimumab for the treatment of intermediate- or poor-risk patients with previously untreated advanced renal cell carcinoma was approved in the U.S. in 2018 and in January 2019 in Europe.

Moreover, efforts of manufacturers to increase number of indications (oncology) for monoclonal antibodies is further expected to boost the market growth over the forecast period. For instance, in June 2018, the U.S. Food & Drug Administration (FDA) expanded the indication of pembrolizumab (Keytruda) to include recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Key features of the study:

· This report provides in-depth analysis of the global monoclonal antibodies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year

· It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

· This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

· It profiles key players in the global monoclonal antibodies market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

· Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG, Eli Lilly and Co., Merck & Co., Inc., GlaxoSmithKline Plc., AbbVie Inc., Bristol-Myers Squibb, and Regeneron Pharmaceuticals Inc.

· Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future launches, market expansion, and marketing tactics

· The global monoclonal antibodies market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts

· Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibodies market

Detailed Segmentation:

· Global Monoclonal Antibodies Market, By Source:

o Human

o Chimeric

o Murine

o Humanized

· Global Monoclonal Antibodies Market, By Application:

o Cancer

o Autoimmune Disease

o Hematological Disease

o Infectious Disease

o Others

· Global Monoclonal Antibodies Market, By Distribution Channel:

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

· Global Monoclonal Antibodies Market, By Region:

o North America

§ By Source:

§ Human

§ Chimeric

§ Murine

§ Humanized

§ By Application:

§ Cancer

§ Autoimmune Disease

§ Hematological Disease

§ Infectious Disease

§ Others

§ By Distribution Channel:

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

§ By Country:

§ U.S.

§ Canada

o Latin America

§ By Source:

§ Human

§ Chimeric

§ Murine

§ Humanized

§ By Application:

§ Cancer

§ Autoimmune Disease

§ Hematological Disease

§ Infectious Disease

§ Others

§ By Distribution Channel:

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

§ By Country:

§ Brazil

§ Mexico

§ Argentina

§ Rest of Latin America

o Europe

§ By Source:

§ Human

§ Chimeric

§ Murine

§ Humanized

§ By Application:

§ Cancer

§ Autoimmune Disease

§ Hematological Disease

§ Infectious Disease

§ Others

§ By Distribution Channel:

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

§ By Country:

§ Germany

§ U.K.

§ France

§ Italy

§ Spain

§ Russia

§ Rest of Europe

o Asia Pacific

§ By Source:

§ Human

§ Chimeric

§ Murine

§ Humanized

§ By Application:

§ Cancer

§ Autoimmune Disease

§ Hematological Disease

§ Infectious Disease

§ Others

§ By Distribution Channel:

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

§ By Country:

§ China

§ India

§ Japan

§ Australia

§ South Korea

§ ASEAN

§ Rest of Asia Pacific

o Middle East

§ By Source:

§ Human

§ Chimeric

§ Murine

§ Humanized

§ By Application:

§ Cancer

§ Autoimmune Disease

§ Hematological Disease

§ Infectious Disease

§ Others

§ By Distribution Channel:

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

§ By Country:

§ GCC

§ Israel

§ Rest of Middle East

o Africa

§ By Source:

§ Human

§ Chimeric

§ Murine

§ Humanized

§ By Application:

§ Cancer

§ Autoimmune Disease

§ Hematological Disease

§ Infectious Disease

§ Others

§ By Distribution Channel:

§ Hospital Pharmacies

§ Retail Pharmacies

§ Online Pharmacies

§ By Country/Region:

§ South Africa

§ Central Africa

§ North Africa

· Company Profiles

o Pfizer Inc.*

§ Company Overview

§ Product Portfolio

§ Financial Performance

§ Key Highlights

§ Market Strategies

o Novartis AG

o Bayer AG

o Sanofi S.A.

o Hoffmann-La Roche AG

o Eli Lilly and Co.

o Merck & Co., Inc.

o GlaxoSmithKline Plc.

o AbbVie Inc.

o Bristol-Myers Squibb

o Regeneron Pharmaceuticals Inc.

https://www.coherentmarketinsights.com/insight/request-sample/2403

https://www.coherentmarketinsights.com/insight/request-pdf/2403

Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2403

CMI Services:https://www.coherentmarketinsights.com/services

About Us:

What we provide:

· Customized Market Research Services

· Industry Analysis Services

· Business Consulting Services

· Market Intelligence Services

· Long term Engagement Model

· Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702